Health insurer Blue Cross Blue Shield just adopted a policy that will force many people with serious asthma and allergy ...

The dispute over who administers these medications follows a long list complaints over health plan rules that seek to ...

This drug discovery process utilizes molecules to bring proteins together to create a desired protein interaction and/or chemical reaction. Until now ... it was thought that molecules this large ...

2002; Scheman et al., 2008). Patients with a neomycin sensitivity may experience a cross-reaction with structurally related antibiotics such as gentamicin (Garamycin®), kanamycin, streptomycin ...

Starting today, Blue Cross Blue Shield will mandate that ... But for at least one of the drugs, Xolair, the reaction can also happen up to a year into treatment. Many families are not comfortable ...

It’s the most commonly reported drug allergy in the U.S. Because of that danger, the FDA requires manufacturers to follow special precautions to prevent cross-contamination with drugs that ...

Because of the high rate of cross-sensitivities and cross-reactions between neomycin and other antibiotics, patients should list neomycin as a medical allergy for the rest of their lives.

15—Patients in five states who have severe asthma and are covered by Blue Cross Blue Shield ... Academy of Pediatrics' drug committee and the American Academy of Allergy Asthma and Immunology's ...